NORTHERN TRUST CORP - IMPEL NEUROPHARMA INC ownership

IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of IMPEL NEUROPHARMA INC
ValueSharesWeighting
Q3 2023$5,684
-66.1%
13,2180.0%0.00%
Q2 2023$16,787
-9.3%
13,2180.0%0.00%
Q1 2023$18,505
-63.1%
13,218
-1.0%
0.00%
Q4 2022$50,082
-23.0%
13,3550.0%0.00%
Q3 2022$65,000
-31.6%
13,355
+30.7%
0.00%
Q2 2022$95,000
-70.1%
10,220
-79.6%
0.00%
Q1 2022$318,000
-25.4%
49,985
+1.3%
0.00%
Q4 2021$426,000
-30.7%
49,322
-2.4%
0.00%
Q3 2021$615,000
+18.7%
50,534
-13.6%
0.00%
Q2 2021$518,00058,4930.00%
Other shareholders
IMPEL NEUROPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
LASRY MARC 408,329$1,989,0003.82%
venBio Partners LLC 2,759,791$13,440,0003.11%
5AM Venture Management, LLC 2,884,791$14,049,0002.69%
Vivo Capital, LLC 2,884,789$14,049,0001.55%
DCF Advisers, LLC 469,183$2,285,0001.48%
Opaleye Management Inc. 255,250$1,243,0000.51%
Kohlberg Kravis Roberts & Co. L.P. 4,135,971$20,142,0000.40%
EPIQ PARTNERS, LLC 18,646$91,0000.06%
GILDER GAGNON HOWE & CO LLC 142,696$695,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 68,300$333,0000.01%
View complete list of IMPEL NEUROPHARMA INC shareholders